A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
diabetes 15 23 15 23 B-chronic_disease
mellitus 24 32 24 32 I-chronic_disease
, 32 33 32 33 O
which 34 39 34 39 O
might 40 45 40 45 O
increase 46 54 46 54 O
the 55 58 55 58 O
risk 59 63 59 63 O
of 64 66 64 66 O
glucose 67 74 67 74 B-clinical_variable
infusion 75 83 75 83 I-clinical_variable

Acute 0 5 84 89 O
symptoms 6 14 90 98 O
( 15 16 99 100 O
7 16 17 100 101 B-upper_bound
days 18 22 102 106 I-upper_bound
duration 23 31 107 115 O
or 32 34 116 118 O
less 35 39 119 123 O
to 40 42 124 126 O
time 43 47 127 131 O
of 48 50 132 134 O
enrollment 51 61 135 145 O
) 61 62 145 146 O
such 63 67 147 151 O
as 68 70 152 154 O
abdominal 71 80 155 164 O
, 80 81 164 165 O
back 82 86 166 170 O
and/or 87 93 171 177 O
limb 94 98 178 182 O
pain 99 103 183 187 O
, 103 104 187 188 O
diagnosed 105 114 189 198 O
by 115 117 199 201 O
the 118 121 202 205 O
investigator 122 134 206 218 O
as 135 137 219 221 O
caused 138 144 222 228 O
by 145 147 229 231 O
porphyria 148 157 232 241 B-chronic_disease
after 158 163 242 247 O
initial 164 171 248 255 O
evaluation 172 182 256 266 O
has 183 186 267 270 O
excluded 187 195 271 279 O
other 196 201 280 285 O
causes 202 208 286 292 O

Diagnosis 0 9 293 302 O
of 10 12 303 305 O
acute 13 18 306 311 O
porphyria 19 28 312 321 O
documented 29 39 322 332 O
by 40 42 333 335 O
a 43 44 336 337 O
substantial 45 56 338 349 O
increase 57 65 350 358 O
in 66 68 359 361 O
urinary 69 76 362 369 O
or 77 79 370 372 O
serum 80 85 373 378 O
porphobilinogen 86 101 379 394 B-chronic_disease
( 102 103 395 396 I-chronic_disease
PBG 103 106 396 399 I-chronic_disease
) 106 107 399 400 I-chronic_disease

For 0 3 401 404 O
acute 4 9 405 410 B-chronic_disease
intermittent 10 22 411 423 I-chronic_disease
porphyria 23 32 424 433 I-chronic_disease
( 33 34 434 435 I-chronic_disease
AIP 34 37 435 438 I-chronic_disease
): 37 39 438 440 I-chronic_disease
Normal 40 46 441 447 O
or 47 49 448 450 O
only 50 54 451 455 O
slight 55 61 456 462 O
increases 62 71 463 472 O
in 72 74 473 475 O
plasma 75 81 476 482 O
and 82 85 483 486 O
fecal 86 91 487 492 O
porphyrins 92 102 493 503 O

For 0 3 504 507 O
hereditary 4 14 508 518 B-chronic_disease
coproporphyria 15 29 519 533 I-chronic_disease
( 30 31 534 535 I-chronic_disease
HCP 31 34 535 538 I-chronic_disease
): 34 36 538 540 I-chronic_disease
Substantial 37 48 541 552 O
increases 49 58 553 562 O
in 59 61 563 565 O
fecal 62 67 566 571 B-treatment
porphyrins 68 78 572 582 I-treatment
( 79 80 583 584 O
almost 80 86 584 590 O
entirely 87 95 591 599 O
coproporphyrin 96 110 600 614 O
III 111 114 615 618 O
) 114 115 618 619 O

For 0 3 620 623 O
variegate 4 13 624 633 B-chronic_disease
porphyria 14 23 634 643 I-chronic_disease
( 24 25 644 645 I-chronic_disease
VP 25 27 645 647 I-chronic_disease
): 27 29 647 649 I-chronic_disease
Substantial 30 41 650 661 O
increases 42 51 662 671 O
in 52 54 672 674 O
fecal 55 60 675 680 O
porphyrins 61 71 681 691 O
( 72 73 692 693 O
mostly 73 79 693 699 O
coproporphyrin 80 94 700 714 O
III 95 98 715 718 O
and 99 102 719 722 O
protoporphyrin 103 117 723 737 O
) 117 118 737 738 O
, 118 119 738 739 O
increased 120 129 740 749 O
plasma 130 136 750 756 O
total 137 142 757 762 O
porphyrins 143 153 763 773 O
and 154 157 774 777 O
a 158 159 778 779 O
fluorescence 160 172 780 792 O
emission 173 181 793 801 O
maximum 182 189 802 809 O
of 190 192 810 812 O
diluted 193 200 813 820 O
plasma 201 207 821 827 O
at 208 210 828 830 O
neutral 211 218 831 838 O
pH 219 221 839 841 O
near 222 226 842 846 O
626 227 230 847 850 O
nm 231 233 851 853 O
. 233 234 853 854 O
Almost 235 241 855 861 O
all 242 245 862 865 O
( 246 247 866 867 O
~95 247 250 867 870 O
percent 251 258 871 878 O
) 258 259 878 879 O
will 260 264 880 884 O
have 265 269 885 889 O
a 270 271 890 891 O
demonstrable 272 284 892 904 O
disease 285 292 905 912 O
- 292 293 912 913 O
causing 293 300 913 920 O
protoporphyrinogen 301 319 921 939 B-treatment
oxidase 320 327 940 947 I-treatment
( 328 329 948 949 I-treatment
PPO 329 332 949 952 I-treatment
) 332 333 952 953 I-treatment
mutation 334 342 954 962 O

Heart 0 5 963 968 B-chronic_disease
failure 6 13 969 976 I-chronic_disease
, 13 14 976 977 O
significant 15 26 978 989 O
chronic 27 34 990 997 O
anemia 35 41 998 1004 B-chronic_disease
or 42 44 1005 1007 O
any 45 48 1008 1011 O
disease 49 56 1012 1019 O
or 57 59 1020 1022 O
condition 60 69 1023 1032 O
that 70 74 1033 1037 O
the 75 78 1038 1041 O
investigator 79 91 1042 1054 O
judges 92 98 1055 1061 O
would 99 104 1062 1067 O
lead 105 109 1068 1072 O
to 110 112 1073 1075 O
an 113 115 1076 1078 O
unacceptable 116 128 1079 1091 O
risk 129 133 1092 1096 O
to 134 136 1097 1099 O
the 137 140 1100 1103 O
patient 141 148 1104 1111 O
or 149 151 1112 1114 O
interfere 152 161 1115 1124 O
with 162 166 1125 1129 O
the 167 170 1130 1133 O
successful 171 181 1134 1144 O
collection 182 192 1145 1155 O
of 193 195 1156 1158 O
date 196 200 1159 1163 O
for 201 204 1164 1167 O
the 205 208 1168 1171 O
trial 209 214 1172 1177 O

Known 0 5 1178 1183 O
or 6 8 1184 1186 O
suspected 9 18 1187 1196 O
allergy 19 26 1197 1204 O
to 27 29 1205 1207 O
Panhematin 30 40 1208 1218 B-allergy_name
â„¢ 40 41 1218 1219 O
or 42 44 1220 1222 O
related 45 52 1223 1230 O
products 53 61 1231 1239 O

Male 0 4 1240 1244 B-gender

Most 0 4 1245 1249 O
( 5 6 1250 1251 O
~90 6 9 1251 1254 O
percent 10 17 1255 1262 O
) 17 18 1262 1263 O
will 19 23 1264 1268 O
have 24 28 1269 1273 O
deficient 29 38 1274 1283 O
activity 39 47 1284 1292 O
of 48 50 1293 1295 O
erythrocyte 51 62 1296 1307 B-treatment
porphobilinogen 63 78 1308 1323 I-treatment
deaminase 79 88 1324 1333 I-treatment
( 89 90 1334 1335 I-treatment
PBGD 90 94 1335 1339 I-treatment
) 94 95 1339 1340 I-treatment
, 95 96 1340 1341 O
and 97 100 1342 1345 O
almost 101 107 1346 1352 O
all 108 111 1353 1356 O
( 112 113 1357 1358 O
> 113 114 1358 1359 O
95 114 116 1359 1361 B-lower_bound
percent 117 124 1362 1369 I-lower_bound
) 124 125 1369 1370 O
will 126 130 1371 1375 O
have 131 135 1376 1380 O
a 136 137 1381 1382 O
demonstrable 138 150 1383 1395 O
disease 151 158 1396 1403 O
- 158 159 1403 1404 O
causing 159 166 1404 1411 O
PBGD 167 171 1412 1416 O
mutation 172 180 1417 1425 O

Preexisting 0 11 1426 1437 O
coagulation 12 23 1438 1449 O
defect 24 30 1450 1456 O
or 31 33 1457 1459 O
concurrent 34 44 1460 1470 O
treatment 45 54 1471 1480 B-treatment
with 55 59 1481 1485 O
an 60 62 1486 1488 O
anticoagulant 63 76 1489 1502 B-treatment

Previously 0 10 1503 1513 O
documented 11 21 1514 1524 O
renal 22 27 1525 1530 B-chronic_disease
impairment 28 38 1531 1541 I-chronic_disease
defined 39 46 1542 1549 O
as 47 49 1550 1552 O
a 50 51 1553 1554 O
serum 52 57 1555 1560 B-clinical_variable
creatinine 58 68 1561 1571 I-clinical_variable
above 69 74 1572 1577 O
1.7 75 78 1578 1581 B-lower_bound
mg 79 81 1582 1584 I-lower_bound
/ 81 82 1584 1585 I-lower_bound
dL 82 84 1585 1587 I-lower_bound
or 85 87 1588 1590 O
150 88 91 1591 1594 B-lower_bound
mmol 92 96 1595 1599 I-lower_bound
/ 96 97 1599 1600 I-lower_bound
L 97 98 1600 1601 I-lower_bound

Therapy 0 7 1602 1609 B-treatment
with 8 12 1610 1614 I-treatment
hemin 13 18 1615 1620 I-treatment
within 19 25 1621 1627 O
7 26 27 1628 1629 B-upper_bound
days 28 32 1630 1634 I-upper_bound
prior 33 38 1635 1640 I-upper_bound
to 39 41 1641 1643 O
enrollment 42 52 1644 1654 O
in 53 55 1655 1657 O
this 56 60 1658 1662 O
study 61 66 1663 1668 O

Type 0 4 1669 1673 O
of 5 7 1674 1676 O
acute 8 13 1677 1682 B-chronic_disease
porphyria 14 23 1683 1692 I-chronic_disease
confirmed 24 33 1693 1702 O
by 34 36 1703 1705 O
additional 37 47 1706 1716 O
testing 48 55 1717 1724 O
( 56 57 1725 1726 O
in 57 59 1726 1728 O
addition 60 68 1729 1737 O
to 69 71 1738 1740 O
increased 72 81 1741 1750 O
PBG 82 85 1751 1754 O
) 85 86 1754 1755 O
, 86 87 1755 1756 O
which 88 93 1757 1762 O
may 94 97 1763 1766 O
be 98 100 1767 1769 O
completed 101 110 1770 1779 O
before 111 117 1780 1786 O
or 118 120 1787 1789 O
after 121 126 1790 1795 O
treatment 127 136 1796 1805 B-treatment
begins 137 143 1806 1812 O
using 144 149 1813 1818 O
pretreatment 150 162 1819 1831 B-treatment
samples 163 170 1832 1839 O

aged 0 4 1840 1844 B-age
18 5 7 1845 1847 B-lower_bound
years 8 13 1848 1853 I-lower_bound

female 0 6 1854 1860 B-gender

